<?xml version="1.0" encoding="UTF-8"?>
<ref id="B20-vaccines-07-00203">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sabchareon</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Wallace</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Sirivichayakul</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Limkittikul</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Chanthavanich</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Suvannadabba</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jiwariyavej</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Dulyachai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Pengsaa</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wartel</surname>
    <given-names>T.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: A randomised, controlled phase 2b trial</article-title>
  <source>Lancet</source>
  <year>2012</year>
  <volume>380</volume>
  <fpage>1559</fpage>
  <lpage>1567</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(12)61428-7</pub-id>
  <pub-id pub-id-type="pmid">22975340</pub-id>
 </element-citation>
</ref>
